Health Decisions is a full-service CRO offering therapeutic, operational and regulatory excellence for the clinical development of assets in all areas of women’s health as well as diagnostics. Health Decisions has supported more than 300 clinical trials, nearly half of which have been in women's health indications including menstrual disorders, contraception, sexual health and menopausal symptoms. It is our wish that every woman has access to the health care that she needs. If it matters to women’s health, it matters to Health Decisions.
In addition, Health Decisions conducts studies of diagnostics in all therapeutic areas. Health Decisions has supported diagnostics development in indications including colorectal cancer, urothelial carcinoma, respiratory indications, sexually transmitted infections as well as tests for amniotic infection and risk of preterm birth. Health Decisions is committed to supporting diagnostics developers as they aim to enable better-informed treatment decisions worldwide. That is why we say: If diagnostics matter to you, you matter to Health Decisions.